Sunshine Biopharma Inc. Increase (Decrease) in Accounts Payable, Related Parties
Sunshine Biopharma Inc. (SBFM) reported Increase (Decrease) in Accounts Payable, Related Parties of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableRelatedParties · last filed 2018-04-02
- Sunshine Biopharma Inc. increase (decrease) in accounts payable, related parties for fiscal 2017 was $0.00.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable, related parties for fiscal 2016 was -$80.00K, a 199.39% decline from fiscal 2015.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable, related parties for fiscal 2015 was $80.49K.
- Sunshine Biopharma Inc. increase (decrease) in accounts payable, related parties for fiscal 2014 was $0.00.
| Period end | Increase (Decrease) in Accounts Payable, Related Parties 12 month | Increase (Decrease) in Accounts Payable, Related Parties 12 month as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-04-02 | |
| 2016-12-31 | -$80.00K 10-K · filed 2018-04-02 | -$80.49K 10-K · filed 2017-04-17 |
| 2015-12-31 | $80.49K 10-K · filed 2017-04-17 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |